The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and genetic analysis for a phase II multicenter trial of HF10, a replication-competent HSV-1 oncolytic immunotherapy, and ipilimumab combination treatment in patients with stage IIIb-IV unresectable or metastatic melanoma.
 
Robert Hans Ingemar Andtbacka
Honoraria - Aduro Biotech; Amgen; Merck/Schering Plough; Novartis
Consulting or Advisory Role - Aduro Biotech; Amgen; Merck/Schering Plough; Novartis
Research Funding - Amgen (Inst); Idera (Inst); Oncolys BioPharma (Inst); OncoSec (Inst); Provectus (Inst); Takara Bio (Inst); Viralytics (Inst); X4 Pharma (Inst)
 
Merrick I. Ross
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Amgen; Merck
 
Sanjiv S. Agarwala
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Matthew H. Taylor
Honoraria - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Trillium Therapeutics
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Eisai; Trillium Therapeutics
Speakers' Bureau - Eisai
 
John T. Vetto
Employment - Roche
Stock and Other Ownership Interests - Roche
Honoraria - Amgen; Castle Biosciences
Speakers' Bureau - Amgen; Castle Biosciences
 
Rogerio Izar Neves
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Research Funding - Penn State Cancer Institute
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Honoraria - EMD Serono; Inovio Pharmaceuticals
Consulting or Advisory Role - Genoptix; GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - patent relating to test for immunotherapy
 
Hung T. Khong
Stock and Other Ownership Interests - Apricus Biosciences; Aptose Biosciences; Array BioPharma; Exelixis; Immunomedics; KaloBios; MEI Pharma; TG Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Richard S. Ungerleider
Employment - Theradex
Leadership - Theradex
 
Maki Tanaka
Employment - Merck (I); Takara Bio